NFKB1 and benign prostatic hyperplasia: In conclusion, our findings demonstrate that nobiletin exerts multi-faceted therapeutic effects against BPH by targeting cell cycle modulation, signaling pathways, and control of NF-κB regulation process (Supplementary Figure S3).